Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Recruiting Observational Study
Alzheimer's Disease MCI Due to AD Dementia Alzheimers
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
208 (estimated)
Sponsor
Hanze University of Applied Sciences Groningen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to Alzheimer's disease ("MCI due to AD") and persons with mild and moderate Alzheimer's disease ("AD"). This study aims to: * Explore motor, speech, and language functions in MCI due to AD and mild and moderate AD. * Combine t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: A subject with MCI with a likelihood of underlying AD pathophysiology must meet the following criteria: * Established diagnosis of MCI due to AD with a likelihood according to NIA-AA criteria (Albert et al., 2011). * A score of stage three on the Global Deterioration Scale (GDS…
Contacts

Marlies Oegema, Master

0031+0505953730

m.oegema@pl.hanze.nl

CONTACT